Residual renal function: Considerations on its importance and preservation in dialysis patients

被引:82
作者
Chandna, SM [1 ]
Farrington, K [1 ]
机构
[1] Lister Hosp, Renal Unit, Stevenage SG1 4AB, Herts, England
关键词
D O I
10.1111/j.0894-0959.2004.17306.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Residual renal function (RRF) remains important even after commencement of dialysis. Its role in the adequacy of peritoneal dialysis (PD) is well recognized and is increasingly utilized in incremental PD regimes, but it is also vitally important in hemodialysis (HD) patients, in whom it, as in PD patients, may improve survival. It may allow for a reduction in the duration of HD sessions. It reduces the need for dietary and fluid restrictions in both PD and HD patients. Other contributions include improved middle molecule clearance, better hemoglobin, phosphate, potassium, and urate levels, enhanced nutritional status and quality of life scores, and better outcomes in pregnancy. On the negative side, hypoalbuminemia may be prolonged in patients with persistent nephrotic-range proteinuria. Contrary to popular belief, RRF does not necessarily decline rapidly with the initiation of HD. PD may be better than HD in preserving RRF, although this difference may not persist if biocompatible membranes, bicarbonate buffer, and ultrapure water are used. Nocturnal ambulatory peritoneal dialysis (APD) patients may fare worse than continuous ambulatory peritoneal dialysis (CAPD) patients. RRF can be adversely affected by angiotensin-converting enzyme (ACE) inhibitors, nonsteroidal anti-inflammatory drugs (NSAIDs), aminoglycosides, and radiocontrast agents. Diuretics can help maintain fluid balance but not RRF.
引用
收藏
页码:196 / 201
页数:6
相关论文
共 105 条
[1]  
Abbassi H, 2001, Gynecol Obstet Fertil, V29, P106, DOI 10.1016/S1297-9589(00)00063-1
[2]  
Aguilera A, 2001, PERITON DIALYSIS INT, V21, pS152
[3]  
Ahmad S, 1979, Proc Eur Dial Transplant Assoc, V16, P107
[4]   RESIDUAL RENAL-FUNCTION IN HEMODIALYSIS-PATIENTS MAY PROTECT AGAINST HYPERALUMINEMIA [J].
ALTMANN, P ;
BUTTER, KC ;
PLOWMAN, D ;
DESAINTONGE, DMC ;
CUNNINGHAM, J ;
MARSH, FP .
KIDNEY INTERNATIONAL, 1987, 32 (05) :710-713
[5]   SERUM BETA-2-MICROGLOBULIN LEVEL AND RESIDUAL RENAL-FUNCTION IN PERITONEAL-DIALYSIS [J].
AMICI, G ;
VIRGA, G ;
DARIN, G ;
GRANDESSO, S ;
VIANELLO, A ;
GATTI, P ;
BOCCI, C .
NEPHRON, 1993, 65 (03) :469-471
[6]   PREGNANCY IN A HEMODIALYSIS PATIENT WITH NO RESIDUAL RENAL-FUNCTION [J].
AMOAH, E ;
ARAB, H .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 17 (05) :585-587
[7]  
[Anonymous], 1980, BRIT J OBSTET GYNAEC, V87, P839
[8]   RENOVASCULAR DISEASE IN OLDER PATIENTS BEGINNING RENAL REPLACEMENT THERAPY [J].
APPEL, RG ;
BLEYER, AJ ;
REAVIS, S ;
HANSEN, KJ .
KIDNEY INTERNATIONAL, 1995, 48 (01) :171-176
[9]   Nephrotoxic effects in high-risk patients undergoing angiography. [J].
Aspelin, P ;
Aubry, P ;
Fransson, S ;
Strasser, R ;
Willenbrock, R ;
Berg, KJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (06) :491-499
[10]   Effect of fluid and sodium removal on mortality in peritoneal dialysis patients [J].
Ates, K ;
Nergizoglu, G ;
Keven, K ;
Sen, A ;
Kutlay, S ;
Ertürk, S ;
Duman, N ;
Karatan, O ;
Ertug, AE .
KIDNEY INTERNATIONAL, 2001, 60 (02) :767-776